182 related articles for article (PubMed ID: 28548078)
21. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R
Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463
[TBL] [Abstract][Full Text] [Related]
22. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
Taraborelli M; Cavazzana I; Martinazzi N; Lazzaroni MG; Fredi M; Andreoli L; Franceschini F; Tincani A
Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
[TBL] [Abstract][Full Text] [Related]
23. The myocarditis of systemic lupus erythematosus: association with myositis.
Borenstein DG; Fye WB; Arnett FC; Stevens MB
Ann Intern Med; 1978 Nov; 89(5 Pt 1):619-24. PubMed ID: 717930
[TBL] [Abstract][Full Text] [Related]
24. [A case of systemic lupus erythematosus predominantly presenting with myositis at onset].
Endo Y; Ikawa M; Takahashi N; Nishino I; Suzuki S; Yoneda M
Rinsho Shinkeigaku; 2013; 53(8):634-7. PubMed ID: 23965856
[TBL] [Abstract][Full Text] [Related]
25. Clinical features and associated factors of abdominal pain in systemic lupus erythematosus.
Yuan S; Lian F; Chen D; Li H; Qiu Q; Zhan Z; Ye Y; Xu H; Liang L; Yang X
J Rheumatol; 2013 Dec; 40(12):2015-22. PubMed ID: 24187097
[TBL] [Abstract][Full Text] [Related]
26. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
27. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
28. Lupus and scleroderma overlap features in a 28-year-old man with anti-PL-12 anti-synthetase syndrome.
Rana J; Moy AP; Piris A; Smith GP
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469721
[TBL] [Abstract][Full Text] [Related]
29. The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression.
Asherson RA; Angus H; Mathews JA; Meyers O; Hughes GR
Ann Rheum Dis; 1991 May; 50(5):323-7. PubMed ID: 2042989
[TBL] [Abstract][Full Text] [Related]
30. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.
Zhao X; Cheng Y; Gan Y; Jia R; Zhu L; Sun X
Clin Rheumatol; 2018 May; 37(5):1229-1237. PubMed ID: 29427009
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus.
Vilá LM; Mayor AM; Valentín AH; García-Soberal M; Vilá S
Lupus; 2000; 9(2):110-5. PubMed ID: 10787007
[TBL] [Abstract][Full Text] [Related]
32. Invasive fungal infections in Colombian patients with systemic lupus erythematosus.
Santamaría-Alza Y; Sánchez-Bautista J; Fajardo-Rivero JF; Figueroa CL
Lupus; 2018 Jun; 27(7):1116-1122. PubMed ID: 29536803
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus].
Liu L; Zhang T; Ye Y; Zhang S; Chen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096
[TBL] [Abstract][Full Text] [Related]
34. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
35. Orbital inflammation, myositis, and systemic lupus erythematosus.
Grimson BS; Simons KB
Arch Ophthalmol; 1983 May; 101(5):736-8. PubMed ID: 6847461
[TBL] [Abstract][Full Text] [Related]
36. Predictors of intestinal pseudo-obstruction in systemic lupus erythematosus complicated by digestive manifestations: data from a Southern China lupus cohort.
Huang Q; Lai W; Yuan C; Shen S; Cui D; Zhao J; Lin J; Ren H; Yang M
Lupus; 2016 Mar; 25(3):248-54. PubMed ID: 26405024
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
[TBL] [Abstract][Full Text] [Related]
38. The lupus patient with positive rheumatoid factor.
Fedrigo A; Dos Santos TAFG; Nisihara R; Skare T
Lupus; 2018 Jul; 27(8):1368-1373. PubMed ID: 29460700
[TBL] [Abstract][Full Text] [Related]
39. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z
Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124
[TBL] [Abstract][Full Text] [Related]
40. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C;
Swiss Med Wkly; 2014; 144():w13990. PubMed ID: 25115978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
